Exiqon A/S
Changes board/management/auditors

Exiqon A/S - Nomination of candidates for the supervisory board

Copenhagen, 2016-07-04 08:39 CEST (GLOBE NEWSWIRE) -- Exiqon has received a proposal from Qiagen N.V. today, where Qiagen N.V. nominates Peer M. Schatz, Roland Sackers and Axel Backheuer as candidates for election to the supervisory board at the extraordinary general meeting on 5 July 2016.

Erik Walldén, Thorleif Krarup, Michael Nobel, Per Wold-Olsen and Rodney Turner will resign as members of the Company's supervisory board while Hans Henrik Chrois Christensen has resigned as Chief Financial Officer.

Additional information

Lars Kongsbak, President and CEO, tel. +45 4566 0888 (cell: +45 4090 2101)

Hans Henrik Chrois Christensen, CFO, phone +45 4566 0888 (cell: +45 4090 2131)

About Exiqon

At Exiqon, we advance the research of when and where genes are expressed. We empower scientists across the world with best-in-class products and user-friendly business solutions designed to transform workflows in our industry. Exiqon operates in two business areas: Exiqon Life Sciences is a leading provider of flexible solutions for gene expression analysis. Academia, biotech and pharmaceutical companies around the world use Exiqon's research products to make ground-breaking discoveries. Exiqon Diagnostics collaborates with diagnostic and pharmaceutical companies to develop novel molecular diagnostic tests for early detection of diseases, which can help physicians make better treatment decisions. Exiqon is listed on Nasdaq Copenhagen. For more information about us, please visit www.exiqon.com

Exiqon A/S published this content on 04 July 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 04 July 2016 06:50:04 UTC.

Original documenthttps://cns.omxgroup.com/cdsPublic/viewDisclosure.action?disclosureId=718640&messageId=900775

Public permalinkhttp://www.publicnow.com/view/B642E41BCE870073C370C1FCF5061CA4DDDEC1DF